Table 1 Characteristics of participants, number (%) unless stated otherwise
| Â | Prolonged CNSD use | ||
|---|---|---|---|
No (n = 146) | Yes (n = 100) | p-value | |
Sex, female | 71 (49) | 66 (66) | 0.009 |
Age in years, mean (SD) | 75 (6.4) | 78 (6.5) | < 0.001 |
Education | |||
 Secondary education | 64 (46) | 31 (33) | 0.001 |
 Higher education | 58 (42) | 33 (35) | |
 Living alone | 59 (40) | 55 (55) | 0.03 |
 Polypharmacy, ≥5 drugs/day | 91 (62) | 92 (92) | < 0.001 |
 Comorbidity burden (CIRS-G scores), mean (SD) | 4.6 (2.2) | 7.7 (2.7) | < 0.001 |
Hospital anxiety and depression scale | |||
 Anxiety score (HADS-A), median (IQR) | 4 (1 to 6) | 4 (2 to 8) | 0.17 |
 Depression score (HADS-D), median (IQR) | 3 (1 to 6) | 4 (2 to 7) | < 0.001 |
 Pain intensity (VAS in centimeters), median (IQR) | 0.7 (0.03 to 2.7) | 2.9 (0.5 to 6.1) | < 0.001 |